Search Results

Benign COVID-19 in an immunocompromised cancer patient -  the case of a married couple.

• Authors : Spezzani V; Family Medicine, Unità Sanitaria Locale del Servizio Sanitario Regionale Emilia-Romagna, Modena, Italy.; Piunno A

Subjects: Anti-Bacterial Agents/Anti-Bacterial Agents/Anti-Bacterial Agents/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*complications

• Source: Swiss medical weekly [Swiss Med Wkly] 2020 Apr 11; Vol. 150, pp. w20246. Date of Electronic Publication: 2020 Apr 11 (Print Publication: 2020).Publisher: Trägerverein Swiss Medical Weekly SMW Country of Publication: Switzerland NLM ID: 100970884 Publication Model: eCollection Cited Medium:

Record details

Reports from University Hospitals of Paris Sud Advance Knowledge in Antivirals (UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma)

• Source: Obesity, Fitness & Wellness Week. April 4, 2020, 4931

Record details

Findings from H. Gouget and Co-Researchers Provides New Data on Antivirals (UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma)

• Source: Obesity, Fitness & Wellness Week. March 1, 2020, 931

Record details

New Findings on Antivirals from H. Gouget and Co-Authors Summarized (UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma)

• Source: Obesity, Fitness & Wellness Week. February 15, 2020, 3133

Record details

Reports from University of Genova Provide New Insights into Antivirals [Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: results from a large multicentre observational prospective cohort (SCOLTA)]

• Source: Obesity, Fitness & Wellness Week. September 14, 2019, 4434

Record details

Research Conducted by E.R. Elliot and Co-Researchers Has Updated Our Knowledge about Antivirals [Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat]

• Source: Obesity, Fitness & Wellness Week. August 10, 2019, 1257

Record details

Study Data from H. Gouget and Colleagues Update Understanding of Antivirals (UPLC-MS/MS method for the simultaneous quantification of bictegravir and 13 others antiretroviral drugs plus cobicistat and ritonavir boosters in human plasma)

• Source: Health & Medicine Week. February 7, 2020, 7326

Record details

Reports on Antivirals Findings from Beaumont Hospital Provide New Insights [Pharmacokinetic enhancers (cobicistat/ritonavir) and the potential for drug-drug interactions]

• Source: AIDS Weekly. December 2, 2019, 144

Record details

New Findings from Wingate University School of Pharmacy Describe Advances in Antivirals (Ritonavir- or cobicistat-boosted antiretroviral therapy and direct oral anticoagulants: A case for apixaban)

• Source: Health & Medicine Week. May 3, 2019, 3636

Record details

Research and Markets Offers Report: Cobicistat (HIV) - Forecast and Market Analysis to 2022.

• Source: Professional Services Close-Up. 2013.

Record details